"Pepsinogens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proenzymes secreted by chief cells, mucous neck cells, and pyloric gland cells, which are converted into pepsin in the presence of gastric acid or pepsin itself. (Dorland, 28th ed) In humans there are 2 related pepsinogen systems: PEPSINOGEN A (formerly pepsinogen I or pepsinogen) and PEPSINOGEN C (formerly pepsinogen II or progastricsin). Pepsinogen B is the name of a pepsinogen from pigs.
| Descriptor ID |
D010435
|
| MeSH Number(s) |
D08.622.509
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pepsinogens".
Below are MeSH descriptors whose meaning is more specific than "Pepsinogens".
This graph shows the total number of publications written about "Pepsinogens" by people in this website by year, and whether "Pepsinogens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1997 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pepsinogens" by people in Profiles.
-
Objective Evidence of Gastro-Esophageal Reflux Disease is Rare in Patients with Autoimmune Gastritis. J Gastrointestin Liver Dis. 2021 Mar 13; 30(1):30-36.
-
Evaluation of serum markers for gastric cancer and its precursor diseases among high incidence and mortality rate of gastric cancer area. Gastric Cancer. 2019 01; 22(1):104-112.
-
Gastric mucosal status in populations with a low prevalence of Helicobacter pylori in Indonesia. PLoS One. 2017; 12(5):e0176203.
-
Plasma pepsinogens, antibodies against Helicobacter pylori, and risk of gastric cancer in the Shanghai Women's Health Study Cohort. Br J Cancer. 2011 Apr 26; 104(9):1511-6.
-
Follow-up testing after treatment of Helicobacter pylori infections: cautions, caveats, and recommendations. Clin Gastroenterol Hepatol. 2011 May; 9(5):373-5.
-
Quantification of serum levels of pepsinogens and gastrin to assess eradication of Helicobacter pylori. Clin Gastroenterol Hepatol. 2011 May; 9(5):440-2.
-
Strategy for eliminating gastric cancer in Japan. Helicobacter. 2010 Dec; 15(6):486-90.
-
Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers. Scand J Gastroenterol. 2007 Jan; 42(1):2-10.
-
Noninvasive versus histologic detection of gastric atrophy in a Hispanic population in North America. Clin Gastroenterol Hepatol. 2006 Mar; 4(3):306-14.
-
Evaluation of cutoff levels for screening of gastric cancer using serum pepsinogens and distributions of levels of serum pepsinogen I, II and of PG I/PG II ratios in a gastric cancer case-control study. J Epidemiol. 1997 Sep; 7(3):143-51.